Publicacions
-
Sheedfar F, Vermeer M, Pazienza V, Villarroya-Terrade J, Rappa F, Cappello F, Mazzoccoli G, Villarroya-Gombau F, van der Molen H, Hofker MH, Koonen DP and Vinciguerra M.
Genetic ablation of macrohistone H2A1 leads to increased leanness, glucose tolerance and energy expenditure in mice fed a high-fat diet.
INTERNATIONAL JOURNAL OF OBESITY . 39(2): 331-338. Nº de cites: 19
-
Domingo P, Lamarca MK, Gallego-Escuredo JM, Torres F, Domingo JC, Villarroya-Terrade J, Gutierrez Mdel M, Mateo MG, Vidal F, Villarroya-Gombau F and Giralt M.
Circulating fibroblast growth factor 23 (FGF23) levels are associated with metabolic disturbances and fat distribution but not cardiovascular risk in HIV-infected patients.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY . 70(6): 1825-1832. Nº de cites: 9
-
Guzmán-Ruiz R, Ortega F, Rodríguez A, Vázquez-Martínez R, Díaz-Ruiz A, Garcia-Navarro S, Giralt M, Garcia-Rios A, Cobo-Padilla D, Tinahones FJ, López-Miranda J, Villarroya-Gombau F, Frühbeck G, Fernández-Real JM and Malagón MM.
Alarmin high-mobility group B1 (HMGB1) is regulated in human adipocytes in insulin resistance and influences insulin secretion in ß-cells.
INTERNATIONAL JOURNAL OF OBESITY . 38(12): 1545-1554. Nº de cites: 72
-
Villarroya-Terrade J, Flachs P, Redondo-Angulo I, Giralt M, Medrikova D, Villarroya-Gombau F, Kopecky J and Planavila A.
Fibroblast growth factor-21 and the beneficial effects of long-chain n-3 polyunsaturated fatty acids.
Lipids . 49(11): 1081-1089. Nº de cites: 19
-
Beiroa D, Imbernon M, Gallego R, Senra A, Herranz D, Villarroya-Gombau F, Serrano M, Fernø J, Salvador J, Escalada J, Dieguez C, Lopez M, Frühbeck G and Nogueiras R.
GLP-1 agonism stimulates brown adipose tissue thermogenesis and browning through hypothalamic AMPK.
Diabetes . 63(10): 3346-3358. Nº de cites: 393
-
Domingo P, Gutierrez Mdel M, Gallego-Escuredo JM, Torres F, Mateo MG, Villarroya-Terrade J, Lamarca K, Domingo JC, Vidal F, Villarroya-Gombau F and Giralt M.
A 48-week study of fat molecular alterations in HIV naive patients starting tenofovir/emtricitabine with lopinavir/ritonavir or efavirenz.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES . 66(5): 457-465. Nº de cites: 13
-
Hondares E, Gallego-Escuredo JM, Flachs P, Frontini A, Cereijo R, Goday A, Perugini J, Kopecky P, Giralt M, Cinti S, Kopecky J and Villarroya-Gombau F.
Fibroblast growth factor-21 is expressed in neonatal and pheochromocytoma-induced adult human brown adipose tissue.
METABOLISM-CLINICAL AND EXPERIMENTAL . 63(3): 312-317. Nº de cites: 67
-
Gallego-Escuredo JM, Villarroya-Terrade J, Domingo P, Targarona EM, Alegre M, Domingo JC, Villarroya-Gombau F and Giralt M.
Differentially altered molecular signature of visceral adipose tissue in HIV-1-associated lipodystrophy.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES . 64(2): 142-148. Nº de cites: 27
-
Palomer FX, Capdevila-Busquets E, Alvarez-Guardia D, Barroso E, Pallàs M, Camins A, Davidson MM, Planavila A, Villarroya-Gombau F and Vazquez M.
Resveratrol induces nuclear factor-?B activity in human cardiac cells.
INTERNATIONAL JOURNAL OF CARDIOLOGY . 167(6): 2507-2516. Nº de cites: 29
-
Villarroya-Gombau F and Vidal-Puig A.
Beyond the sympathetic tone: the new brown fat activators.
CELL METABOLISM . 17(5): 638-643. Nº de cites: 167